Evaluating the Effects of Nusinersen Treatment in Adults With Spinal Muscular Atrophy Using Axonal Excitability and MscanFit MUNE
Muscle & Nerve · 2025
DOI: 10.1002/mus.28476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Abir Alaamel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Neurology, Akdeniz University, Antalya, Türkiye. Hauptthemen laut MEDLINE: Oligonucleotides, Muscular Atrophy, Spinal, Axons. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction/Aims The biological changes in motor neurons and motor axons that correlate with the clinical benefits of nusinersen, an antisense oligonucleotide, in spinal muscular atrophy (SMA) remain poorly understood. This study aimed to investigate changes in axonal excitability and motor unit number estimation (MUNE) parameters following a four‐dose loading regimen of nusinersen in adult SMA patients.
Methods
Adult patients with SMA were assessed using the Hammersmith Functional Motor Scale Expanded (HFMSE) and the Medical Research Council (MRC) scale at baseline and after nusinersen treatment. Axonal excitability studies and MScanFit MUNE were conducted in SMA patients before and after treatment. Baseline axonal excitability and MScanFit MUNE parameters in SMA patients were compared with those of a healthy control (HC) group.
Results
Compared to the HC group ( n = 10), SMA patients ( n = 12) exhibited a significantly prolonged strength‐duration time constant (SDTC), a higher resting current/voltage (I/V) slope, and prolonged refractoriness at 2.5 ms. However, no significant changes in axonal excitability parameters were observed following nusinersen treatment. Similarly, there were no significant changes in MUNE or in other parameters, including D50, compound muscle action potentials, and steps%. In contrast, a significant increase in HFMSE and MRC scores was observed after treatment ( p < 0.01 and p = 0.01, respectively).
Discussion
A prolongation of SDTC, likely due to its effect on sodium channel function, was observed in this study, consistent with existing literature. Despite improvements in motor function, no significant electrophysiological changes were detected in adult SMA patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Neurology, Akdeniz University, Antalya, Türkiye.
- Department of Neurology, Private ASV Yasam Hospital, Antalya, Türkiye.
- Faculty of Health Sciences, Akdeniz University, Antalya, Türkiye.
ORCID-Profile: Abir Alaamel, Hilmi Uysal
Zitieren
APA
Alaamel, A., Erdem, N. Ş., Gencer, G. Y. G., Kaya, H. C., & Uysal, H. (2025). Evaluating the Effects of Nusinersen Treatment in Adults With Spinal Muscular Atrophy Using Axonal Excitability and MscanFit MUNE. Muscle & Nerve. https://doi.org/10.1002/mus.28476
Vancouver
Alaamel A, Erdem NŞ, Gencer GYG, Kaya HC, Uysal H. Evaluating the Effects of Nusinersen Treatment in Adults With Spinal Muscular Atrophy Using Axonal Excitability and MscanFit MUNE. Muscle & Nerve. 2025. doi:10.1002/mus.28476
BibTeX
@article{Alaamel2025,
author = {Alaamel, Abir and Erdem, Nazan Şimşek and Gencer, Gökçe Yağmur Güneş and Kaya, Hüseyin Can and Uysal, Hilmi},
title = {Evaluating the Effects of Nusinersen Treatment in Adults With Spinal Muscular Atrophy Using Axonal Excitability and MscanFit MUNE},
journal = {Muscle & Nerve},
year = {2025},
doi = {10.1002/mus.28476}
}
EUVIMED